co.don AG IPO-Jahr
Was ist das IPO-Jahr von co.don AG?
IPO-Jahr von co.don AG ist 2001
Was ist die Definition von IPO-Jahr?
Börsengang ist ein öffentliches Angebot, bei dem Aktien eines Unternehmens normalerweise an institutionelle Anleger verkauft werden, die ihrerseits erstmals an einer Wertpapierbörse an die breite Öffentlichkeit verkauft werden.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
IPO-Jahr von Unternehmen in Health Care Sektor auf XETRA im Vergleich zu co.don AG
Was macht co.don AG?
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide. The company develops, produces, and markets autologous cell therapies for the minimally invasive repair of cartilage damage to knee joints following traumatic or degenerative defects. Its therapies include matrix-associated autologous cartilage transplantation, a biological therapy for the treatment of damaged articular cartilage with the body's own cells; and autologous chondrocyte transplantation for the regeneration of biomechanical load-bearing and pressure-resistant cartilage tissue. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
Unternehmen mit ipo-jahr ähnlich co.don AG
- DTE Co hat IPO-Jahr von 2000
- Compagnie des Tramways de Rouen hat IPO-Jahr von 2000
- China Energine International () hat IPO-Jahr von 2000
- Sterlite Technologies hat IPO-Jahr von 2000
- Polished.com Inc hat IPO-Jahr von 2000
- Hexaware Technologies hat IPO-Jahr von 2000
- co.don AG hat IPO-Jahr von 2001
- Essel Propack hat IPO-Jahr von 2002
- CME Inc hat IPO-Jahr von 2002
- Mangalam Timber Products hat IPO-Jahr von 2002
- Petropavlovsk Plc hat IPO-Jahr von 2002
- Sino Oil and Gas hat IPO-Jahr von 2002
- Jost's Engineering hat IPO-Jahr von 2002